Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle

Fernando R. Báu, Fabiola Z.T. Mónica, Fernanda Priviero, Lineu Baldissera, Gilberto de Nucci, Edson Antunes

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The nitric oxide (NO)-independent soluble guanylyl cyclase stimulator stimulator BAY 41-2272 was reported to produce relaxant response in different types of smooth muscle. However no study was carried out to investigate the effects of BAY 412282 in detrusor smooth muscle. Thus, this study aimed to evaluate the relaxant effects of BAY 41-2272, in isolated mouse, rat and rabbit detrusor smooth muscle. Mouse, rat and rabbit were anesthetized, and urinary bladder removed. Detrusor smooth muscle was transferred to 10-mL organ baths containing oxygenated and warmed Krebs-Henseleit solution. Tissues were connected to force-displacement transducers and changes in isometric force were recorded. BAY 41-2272 (0.001-100μM) produced concentration-dependent detrusor smooth muscle relaxations in mouse, rat and rabbit with maximal responses of 61.3±6.6%, 95.1±9.9% and 91.7±5.9%, respectively. Sodium nitroprusside and glyceryl trinitrate, as well as 8-bromo-cGMP also produced detrusor relaxations, but to a much lesser extent than BAY 41-2272. The NO synthesis inhibitor L-NAME and the phosphodiesterase-5 inhibitor sildenafil had no effect in BAY 41-2272-induced responses. However, the soluble guanylyl cyclase inhibitor ODQ significantly reduced BAY 41-2272-induced relaxations. BAY 41-2272 increased the bladder cGMP levels by about of 14- and 20-fold for 10 and 100μM, respectively, which were markedly reduced by ODQ. The cAMP levels were unaffected by BAY 41-2272. Moreover, BAY 41-2272 significantly reduced the contractile responses to extracellular Ca2+ in an ODQ-insensitive manner. In conclusion, rabbit detrusor smooth muscle relaxations by BAY 41-2272 involve mainly cGMP production, but an additional mechanism involving Ca2+ influx blockade independently of cGMP production appears to be involved.

Original languageEnglish (US)
Pages (from-to)171-177
Number of pages7
JournalEuropean Journal of Pharmacology
Volume637
Issue number1-3
DOIs
StatePublished - Jul 1 2010
Externally publishedYes

Fingerprint

Smooth Muscle
Nitric Oxide
Rabbits
Muscle Relaxation
Urinary Bladder
Soluble Guanylyl Cyclase
3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridine
Phosphodiesterase 5 Inhibitors
NG-Nitroarginine Methyl Ester
Nitroglycerin
Nitroprusside
Transducers
Baths

Keywords

  • BAY 41-2272
  • Calcium channel
  • Cyclic GMP
  • Detrusor smooth muscle
  • Potassium channel

ASJC Scopus subject areas

  • Pharmacology

Cite this

Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle. / Báu, Fernando R.; Mónica, Fabiola Z.T.; Priviero, Fernanda; Baldissera, Lineu; de Nucci, Gilberto; Antunes, Edson.

In: European Journal of Pharmacology, Vol. 637, No. 1-3, 01.07.2010, p. 171-177.

Research output: Contribution to journalArticle

Báu, Fernando R. ; Mónica, Fabiola Z.T. ; Priviero, Fernanda ; Baldissera, Lineu ; de Nucci, Gilberto ; Antunes, Edson. / Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle. In: European Journal of Pharmacology. 2010 ; Vol. 637, No. 1-3. pp. 171-177.
@article{7814ad116a3b4802887174e9778786bd,
title = "Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle",
abstract = "The nitric oxide (NO)-independent soluble guanylyl cyclase stimulator stimulator BAY 41-2272 was reported to produce relaxant response in different types of smooth muscle. However no study was carried out to investigate the effects of BAY 412282 in detrusor smooth muscle. Thus, this study aimed to evaluate the relaxant effects of BAY 41-2272, in isolated mouse, rat and rabbit detrusor smooth muscle. Mouse, rat and rabbit were anesthetized, and urinary bladder removed. Detrusor smooth muscle was transferred to 10-mL organ baths containing oxygenated and warmed Krebs-Henseleit solution. Tissues were connected to force-displacement transducers and changes in isometric force were recorded. BAY 41-2272 (0.001-100μM) produced concentration-dependent detrusor smooth muscle relaxations in mouse, rat and rabbit with maximal responses of 61.3±6.6{\%}, 95.1±9.9{\%} and 91.7±5.9{\%}, respectively. Sodium nitroprusside and glyceryl trinitrate, as well as 8-bromo-cGMP also produced detrusor relaxations, but to a much lesser extent than BAY 41-2272. The NO synthesis inhibitor L-NAME and the phosphodiesterase-5 inhibitor sildenafil had no effect in BAY 41-2272-induced responses. However, the soluble guanylyl cyclase inhibitor ODQ significantly reduced BAY 41-2272-induced relaxations. BAY 41-2272 increased the bladder cGMP levels by about of 14- and 20-fold for 10 and 100μM, respectively, which were markedly reduced by ODQ. The cAMP levels were unaffected by BAY 41-2272. Moreover, BAY 41-2272 significantly reduced the contractile responses to extracellular Ca2+ in an ODQ-insensitive manner. In conclusion, rabbit detrusor smooth muscle relaxations by BAY 41-2272 involve mainly cGMP production, but an additional mechanism involving Ca2+ influx blockade independently of cGMP production appears to be involved.",
keywords = "BAY 41-2272, Calcium channel, Cyclic GMP, Detrusor smooth muscle, Potassium channel",
author = "B{\'a}u, {Fernando R.} and M{\'o}nica, {Fabiola Z.T.} and Fernanda Priviero and Lineu Baldissera and {de Nucci}, Gilberto and Edson Antunes",
year = "2010",
month = "7",
day = "1",
doi = "10.1016/j.ejphar.2010.04.008",
language = "English (US)",
volume = "637",
pages = "171--177",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle

AU - Báu, Fernando R.

AU - Mónica, Fabiola Z.T.

AU - Priviero, Fernanda

AU - Baldissera, Lineu

AU - de Nucci, Gilberto

AU - Antunes, Edson

PY - 2010/7/1

Y1 - 2010/7/1

N2 - The nitric oxide (NO)-independent soluble guanylyl cyclase stimulator stimulator BAY 41-2272 was reported to produce relaxant response in different types of smooth muscle. However no study was carried out to investigate the effects of BAY 412282 in detrusor smooth muscle. Thus, this study aimed to evaluate the relaxant effects of BAY 41-2272, in isolated mouse, rat and rabbit detrusor smooth muscle. Mouse, rat and rabbit were anesthetized, and urinary bladder removed. Detrusor smooth muscle was transferred to 10-mL organ baths containing oxygenated and warmed Krebs-Henseleit solution. Tissues were connected to force-displacement transducers and changes in isometric force were recorded. BAY 41-2272 (0.001-100μM) produced concentration-dependent detrusor smooth muscle relaxations in mouse, rat and rabbit with maximal responses of 61.3±6.6%, 95.1±9.9% and 91.7±5.9%, respectively. Sodium nitroprusside and glyceryl trinitrate, as well as 8-bromo-cGMP also produced detrusor relaxations, but to a much lesser extent than BAY 41-2272. The NO synthesis inhibitor L-NAME and the phosphodiesterase-5 inhibitor sildenafil had no effect in BAY 41-2272-induced responses. However, the soluble guanylyl cyclase inhibitor ODQ significantly reduced BAY 41-2272-induced relaxations. BAY 41-2272 increased the bladder cGMP levels by about of 14- and 20-fold for 10 and 100μM, respectively, which were markedly reduced by ODQ. The cAMP levels were unaffected by BAY 41-2272. Moreover, BAY 41-2272 significantly reduced the contractile responses to extracellular Ca2+ in an ODQ-insensitive manner. In conclusion, rabbit detrusor smooth muscle relaxations by BAY 41-2272 involve mainly cGMP production, but an additional mechanism involving Ca2+ influx blockade independently of cGMP production appears to be involved.

AB - The nitric oxide (NO)-independent soluble guanylyl cyclase stimulator stimulator BAY 41-2272 was reported to produce relaxant response in different types of smooth muscle. However no study was carried out to investigate the effects of BAY 412282 in detrusor smooth muscle. Thus, this study aimed to evaluate the relaxant effects of BAY 41-2272, in isolated mouse, rat and rabbit detrusor smooth muscle. Mouse, rat and rabbit were anesthetized, and urinary bladder removed. Detrusor smooth muscle was transferred to 10-mL organ baths containing oxygenated and warmed Krebs-Henseleit solution. Tissues were connected to force-displacement transducers and changes in isometric force were recorded. BAY 41-2272 (0.001-100μM) produced concentration-dependent detrusor smooth muscle relaxations in mouse, rat and rabbit with maximal responses of 61.3±6.6%, 95.1±9.9% and 91.7±5.9%, respectively. Sodium nitroprusside and glyceryl trinitrate, as well as 8-bromo-cGMP also produced detrusor relaxations, but to a much lesser extent than BAY 41-2272. The NO synthesis inhibitor L-NAME and the phosphodiesterase-5 inhibitor sildenafil had no effect in BAY 41-2272-induced responses. However, the soluble guanylyl cyclase inhibitor ODQ significantly reduced BAY 41-2272-induced relaxations. BAY 41-2272 increased the bladder cGMP levels by about of 14- and 20-fold for 10 and 100μM, respectively, which were markedly reduced by ODQ. The cAMP levels were unaffected by BAY 41-2272. Moreover, BAY 41-2272 significantly reduced the contractile responses to extracellular Ca2+ in an ODQ-insensitive manner. In conclusion, rabbit detrusor smooth muscle relaxations by BAY 41-2272 involve mainly cGMP production, but an additional mechanism involving Ca2+ influx blockade independently of cGMP production appears to be involved.

KW - BAY 41-2272

KW - Calcium channel

KW - Cyclic GMP

KW - Detrusor smooth muscle

KW - Potassium channel

UR - http://www.scopus.com/inward/record.url?scp=77953288656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953288656&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2010.04.008

DO - 10.1016/j.ejphar.2010.04.008

M3 - Article

C2 - 20399768

AN - SCOPUS:77953288656

VL - 637

SP - 171

EP - 177

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -